Evaluation of Rexon-Eye Efficacy for Dry Eye Subjects

  • Research type

    Research Study

  • Full title

    Evaluation of Rexon-Eye Efficacy in Symptomatic Contact Lens Wearers and Dry Eye Sufferers.

  • IRAS ID

    241614

  • Contact name

    Kishan Patel

  • Contact email

    kpatel@otg.co.uk

  • Sponsor organisation

    CooperVision, Inc.

  • Duration of Study in the UK

    0 years, 6 months, 20 days

  • Research summary

    A number of instruments have been developed to offer in-office dry eye treatment, which application can extend to treating contact lens discomfort. A new device, Rexon-Eye has received CE marking to treat both evaporative and aqueous deficient dry eyes. The technology is based upon quantum molecular resonance (QMS). The device produces low power, high frequency current delivered through an eye mask over closed eyes to increase cellular regeneration, hence reactivating the tear system. The claim is that QMS increases cellular regeneration and is therefore beneficial in treating ocular tissue anomalies in dry eye subjects by stimulating both the tear gland that produces aqueous tears and the mucin producing goblet cells. The purpose of this study is to measure the effect of using CE marked Rexon-Eye device for dry eye treatment on contact lens wearers with dry eye symptoms and dry eye sufferers who do not wear contact lenses. The effect on (i) symptomatology, (ii) ocular tissue anomalies and (iii) tear volume will be evaluated. Fifty four adults will be enrolled; 30 subjects will be existing daily disposable contact lens wearers with discomfort/dry eye symptoms and 24 subjects will be dry eye sufferers who do not wear contact lenses. Subjects will be randomised to the active treatment group (test) or control (output set at 0) in a 2 to 1 ratio. The study will involve six study visits over approximately a four-month period. There will be baseline/enrollment visit, 4 weekly 20-minute treatment sessions with the device and a 3 month follow up visit. The treatment will be administered at the study site only. The participant and investigator will be masked.\n\n

  • REC name

    South West - Cornwall & Plymouth Research Ethics Committee

  • REC reference

    18/SW/0026

  • Date of REC Opinion

    14 Feb 2018

  • REC opinion

    Further Information Favourable Opinion